Toshimasa Harumoto

Title: Innovations of Toshimasa Harumoto

Introduction

Toshimasa Harumoto is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. With a total of two patents to his name, Harumoto's work showcases his expertise and innovative spirit.

Latest Patents

Harumoto's latest patents include a nucleic acid conjugate and a bispecific antibody. The nucleic acid conjugate involves a sugar chain ligand bonded to an oligonucleotide via a linker, featuring O-bonded mannose at its non-reducing end. This invention has potential applications in targeted drug delivery and gene therapy. The bispecific antibody is designed to bind to CD116 and CD131, providing agonist activity to a GM-CSF receptor. This invention includes a first antigen-binding domain and a second antigen-binding domain, enhancing its therapeutic potential.

Career Highlights

Harumoto is currently employed at Kyowa Kirin Co., Ltd., a leading biopharmaceutical company. His work at the company focuses on advancing innovative treatments for various diseases. His contributions have been instrumental in the development of new therapeutic strategies.

Collaborations

Some of Harumoto's coworkers include Akifumi Kato and Harue Nishiya. Their collaborative efforts contribute to the innovative environment at Kyowa Kirin Co., Ltd.

Conclusion

Toshimasa Harumoto's inventions reflect his dedication to advancing biotechnology. His patents demonstrate the potential for significant advancements in therapeutic applications. His work continues to inspire innovation in the field.